Caboo$e money
The health care / bio-tech space has done exceptionally well over the last couple years. I met with my investment advisor last week, and he pointed to a health care fund I have for my grandkids...up 48% over the last year, and an average of over 25% over 3 years. If you look closely at the Canadian stories you'll notice there have been some substantial winners with argualy a lot less to offer than say a "Spectral" or a "Bioniche". I watch very closely and believe the flow of money through the tiny world of Canadian bio-tech is far more organized than you could imagine. In my humble opinion, I believe it will pay to be at the "end of the train" when it comes to making a move in this space. Big thinkers are moving money from one story to another...let's have a quick look at some trains that have already reached their destination:
* YM Bio - taken out at $3/share ( 500M valuation includes 140K of cash ) PHASE II
* Thallion ( TLN ) - moved from .06 and taken out at .20
* Medicago ( MDG ) - movedfrom .30's taken out at 1.15
* Resverlogix ( RVX ) - run to almost $4 failed phase III moved to .15 back to >$1 now at .60
* PLI - run to 1.14 from .14 - now at .97 financing at .90...will be .30 in 4 months - IMO
* RBM - run to $5 on ? now at $2 ....smal float
etc.....
The money gathered by smart money from the above situations will be looking for another ride,....I say Spectral and Bioniche will be future vehicles.
Sqr